Patent Assignment
Reel/Frame 050053/0705
Change of Name
Recorded: 2019-08-14
Pages: 3
Assignor
ZENITH EPIGENETICS CORP.
Executed: 2016-08-01
Assignee
ZENITH CAPITAL CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property
(1)
Substituted Bicyclic Compounds as Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 14, 2019
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 050052/0509 →
General Conveyance and Assumption Agreement
Aug 14, 2019
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENTICS CORP.
Reel/Frame 050053/0343 →
Assignment of Assignor's Interest
Aug 14, 2019
From: LIU, SHUANG; DUFFY, BRYAN CORDELL; WANG, RUIFANG; JIANG, MAY XIAOWU
To: RVX THERAPEUTICS INC.
Reel/Frame 050053/0352 →
Assignment of Assignor's Interest
Aug 14, 2019
From: LIU, SHUANG; QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 050053/0460 →